Using cloud-based technology, artificial intelligence and machine learning, the two health systems will aggregate clinical deidentified data, according to a July 26 news release from Mercy. The information will help scientists analyze patterns of effective disease treatment and disease prevention in new ways based upon longitudinal data review over an extended period.
“With Mayo and Mercy combining efforts, we can speed prediction and diagnosis and provide better patient care, experience and outcomes, while ultimately saving more lives,” said Steve Mackin, president and CEO of Mercy. “We also hope to innovate together in other patient-focused areas, including precision medicine, transplant care, complex cancer, cardiovascular, neuroscience and much more. Together, we have the opportunity to do something for the greater good, be proactive and change healthcare for patients everywhere.”
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
